Article
Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation.
Journal of pediatric endocrinology & metabolism : JPEM - 1 May 2015
Shah Pratik, Arya Ved Bhushan, Flanagan Sarah E, Morgan Kate, Ellard Sian, Senniappan Senthil, Hussain Khalid
Abstract excerpt
INTRODUCTION: Hyperinsulinaemic hypoglycaemia (HH) is the most common cause of severe and persistent hypoglycaemia in neonates. The treatment of severe diazoxide unresponsive HH involves near total pancreatectomy. Mammalian target of rapamycin (mTOR) is a protein kinase that regulates cellular proliferation. mTOR inhibitors are used in cancer patients and recently found to be effective in the treatment of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
